5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1. 2012

Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
College of Pharmacy, Sookmyung Women's University, Seoul 140-742, Republic of Korea.

5-Lipoxygenase (5-LO) catalyzes the formation of two major groups of leukotrienes, leukotriene B4 and cysteinyl leukotrienes (CysLTs), and it has been implicated as a promising drug target to treat various inflammatory diseases. However, its role in osteoclastogenesis has not been investigated. In this study, we used mouse bone marrow-derived macrophages (BMMs) to show that 5-LO inhibitor suppresses RANKL-induced osteoclast formation. Inhibition of 5-LO was associated with impaired activation of multiple signaling events downstream of RANK, including ERK and p38 phosphorylation, and IκB degradation, followed by a decrease in NFATc1 expression. Ectopic overexpression of a constitutively active form of NFATc1 partly rescued the antiosteoclastogenic effect of 5-LO inhibitor. The knockdown of 5-LO in BMMs also resulted in a significant reduction in RANKL-induced osteoclast formation, accompanied by decreased expression of NFATc1. Similar effects were shown with CysLT receptor (CysLTR)1/2 antagonist and small RNA for CysLTR1 in BMMs, indicating the involvement of CysLT and CysLTR1 in 5-LO-mediated osteoclastogenesis. Finally, 5-LO inhibitor suppressed LPS-induced osteoclast formation and bone loss in the in vivo mouse experiments, suggesting a potential therapeutic strategy for treating diseases involving bone destruction. Taken together, the results of this study demonstrate that 5-LO is a key mediator of RANKL-induced osteoclast formation and possibly a novel therapeutic target for bone-resorption diseases.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
July 2014, Brain research,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
March 2015, Journal of immunology (Baltimore, Md. : 1950),
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
October 2021, Experimental lung research,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
April 2002, The Journal of allergy and clinical immunology,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
January 2018, Artificial cells, nanomedicine, and biotechnology,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
July 2007, Acta pharmacologica Sinica,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
January 2022, PloS one,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
January 2014, Acta pharmacologica Sinica,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
October 2015, Die Pharmazie,
Jung-Min Lee, and Hyojung Park, and A Long Sae Mi Noh, and Ju-Hee Kang, and Ling Chen, and Ting Zheng, and Juhyun Lee, and Sun-Young Ji, and Chang-Young Jang, and Chan Soo Shin, and Hyunil Ha, and Zang Hee Lee, and Hea-Young Park, and Dong-Seok Lee, and Mijung Yim
June 2012, Journal of neuroinflammation,
Copied contents to your clipboard!